SunLink Health Systems, Inc. announced that its Board of Directors had approved a share repurchase program that authorizes the Company to purchase up to 300,000 shares of its common stock or approximately 4% of its currently outstanding shares.

Under the share repurchase program, the Company may repurchase shares in open market and privately negotiated transactions and block trades in accordance with applicable securities laws and regulations. The extent to which the Company repurchases its shares, and the timing of such repurchases, will depend upon a number of factors, including business and market conditions, regulatory requirements and other corporate considerations determined by the Company’s management. There is no assurance as to the exact number of shares, if any, that will be repurchased by the Company. The share repurchase program does not have an expiration date and may be modified, terminated or extended by the company without prior notice.

The Company expects to fund any repurchases with cash on hand or from future cash flow.